Late recurrence of clinical stage I seminoma of the testis after 12 years despite adjuvant infradiaphragmatic irradiation

Late recurrent seminoma: 18 years after bilateral orchidectomy in patient with bilateral stage one testicular seminoma

Late recurrence of stage I seminoma is an uncommon event. We reported a patient with seminoma recurred 18 years after the initial bilateral orchidectomy for bilateral stage I seminoma. He was on surveillance after the initial treatment and remained disease free for 18 years. He then presented with liver mass and diagnosed as recurrent seminoma. Systemic chemotherapy and subsequent hepatectomy for residual hepatic tumour mass were performed and the disease was cleared. The incidence and management of the late recurrence of seminoma would be discussed.

Late recurrence and salvage therapy of CNS germinomas

Central nervous system (CNS) germinoma is a curable tumor and its recurrence rate after initial therapy may be approximately 10% or higher. This study elucidates the time-course of recurrence and results of salvage therapy. Twenty-five patients with recurrent germinoma treated at Hokkaido University Hospital were retrospectively reviewed. The median age at initial treatment was 12 years (range: 8-37). All patients had been tumor-free for at least 6 months after the initial treatment. The median follow-up period was 134 months (range: 44-338). The median age at first recurrence was 18 years and the median time to the first recurrence was 50 months. Among the patients, 9 (36%) had the first recurrence at 60 months or later. The latest recurrence in a patient occurred 230 months after the initial treatment. The results of salvage therapy were estimated in all 25 patients. Seventeen patients (68%) were salvaged and were tumor-free at the final observation. The remaining 8 patients died of disease. At first recurrence, 11 patients were treated using radiation therapy with or without surgery and 7 out of the 11 patients died due to the recurrent tumor. On the other hand, 13 patients who received salvage chemotherapy and radiotherapy were tumor-free at the last follow-up. In conclusion, late recurrence is not a rare event in patients with CNS germinoma. To identify a true cure rate of this disease, a 10-year or longer observation period may be required. As a salvage therapy, platinum-based chemotherapy followed by wide-field low-dose radiation therapy appears to be effective.